GBT
AVNS

Grove Bank & Trust’s Avanos Medical AVNS Stock Holding History

Grove Bank & Trust’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-120
Closed -$5K – 578
2017
Q2 		$5K Buy
+120
New +$4.53K ﹤0.01% 553
2016
Q2 		– Sell
-50
Closed -$1K – 272
2016
Q1 		$1K Hold
50
– – ﹤0.01% 260
2015
Q4 		$2K Buy
+50
New +$1.55K ﹤0.01% 320

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Grove Bank & Trust's AVNS Position: Q3 2017 in Review

Grove Bank & Trust sold out of Avanos Medical (AVNS) in Q3 2017, closing a stake of 120 shares — an estimated $5K sold.

Grove Bank & Trust first reported a position in AVNS in Q4 2015 and held it in 3 quarters. The position peaked at $5K in Q2 2017. 318 funds tracked by Wall St. Rank hold AVNS as of Q3 2017.

  • Grove Bank & Trust reported no remaining Avanos Medical position as of Q3 2017 after selling out during the quarter.
  • Grove Bank & Trust sold 120 Avanos Medical shares in Q3 2017, an estimated $5K.
  • Grove Bank & Trust first reported a position in Avanos Medical in Q4 2015 and held it in 3 quarters.
  • Grove Bank & Trust's Avanos Medical position peaked at $5K in Q2 2017.
  • 318 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2017.

Based on Grove Bank & Trust's 13F filing for Q3 2017, filed 13 Nov 2017.